Table 5 Univariate and multivariable Cox proportional hazards model for PFS
From: Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas
Characteristic | Univariate analysis | Multivariable analysis | ||
|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | |
Age | ||||
≤ 55 vs. >55 | 0.823 (0.490–1.382) | 0.462 | 0.783 (0.456–1.343) | 0.374 |
Sex | ||||
Female vs. Male | 0.612 (0.357–1.049) | 0.074 | 0.552 (0.301–1.016) | 0.056 |
Location | ||||
Mucosa vs. Skin | 2.636 (1.230–5.680) | 0.013* | 2.644 (1.085–6.442) | 0.032* |
Acral vs. Skin | 2.064 (0.823–5.173) | 0.122 | 2.018 (0.723–5.630) | 0.180 |
Other vs. Skin | 1.186 (0.395–3.558) | 0.761 | 0.844 (0.460–1.549) | 0.584 |
Neuroendocrinea | 0.854 (0.510–1.432) | 0.550 | 0.844 (0.460–1.549) | 0.584 |
BRAF alternations | 0.797 (0.452–1.406) | 0.434 | 1.035 (0.517–2.069) | 0.923 |
Stage | ||||
III vs. I-II | 1.084 (0.591–1.986) | 0.795 | 1.197 (0.601–2.384) | 0.610 |
IV vs. I-II | 0.946 (0.291–3.076) | 0.927 | 0.919 (0.267–3.160) | 0.893 |